Virtual Cancer Consultation Services

Mark Simon's journey into cancer research began in 2004, building on a lifelong study of plant-based nutrition, holistic health, and natural medicine that dates back to 1982. Driven by a steadfast belief that nutritional intervention and natural agents can complement conventional care, Mark founded NORI in 2011 to give cancer patients — including those facing cervical cancer — powerful, science-based tools for ongoing wellness and long-term management. Under his leadership, NORI has developed the proprietary NORI Protocol, a cycled methionine restriction program that supports metabolic health in cancer patients. Mark oversees all program development, nutraceutical formulation, and client support, ensuring every patient receives individualized care grounded in the latest nutritional oncology research.

Dr. Robert M. Hoffman brings over 55 years of dedicated cancer research experience to the NORI advisory team. As CEO of AntiCancer, Inc. and a world-renowned cancer biologist, Dr. Hoffman has authored hundreds of peer-reviewed publications and holds numerous patents in oncology research. His deep scientific expertise directly informs the NORI Protocol's evidence-based approach to supporting metabolic health in cancer patients through nutritional and nutraceutical intervention. Dr. Hoffman's advisory role ensures that NORI's cervical cancer integrative support programs remain at the forefront of nutritional oncology science, bridging rigorous academic research with accessible, real-world application for patients worldwide.

Dr. Daniel Thomas is a seasoned integrative oncologist with 35 years of clinical experience combining conventional and natural medicine to support cancer patients. As a Doctor of Osteopathic Medicine with a strong background in integrative oncology, Dr. Thomas provides NORI with invaluable clinical insight into how nutritional therapies complement — and complement — standard cancer care. His decades of hands-on patient experience inform NORI's approach to cervical cancer integrative care, ensuring that every protocol recommendation is both scientifically sound and practically applicable for real patients navigating a diagnosis. Dr. Thomas's guidance strengthens NORI's commitment to safe, holistic, and effective cancer support.

Mark Simon has dedicated his career to revolutionizing cancer care through nutritional intervention. His journey in plant-based nutrition, holistic health, and natural medicine began in 1982, laying a foundation for what would become a groundbreaking approach to oncology. In 2004, Mark intensified his focus specifically on cancer research, driven by a strong conviction that nutritional intervention and natural agents can complement conventional care. This passion led him to establish NORI in 2011, creating an organization that would offer cancer patients powerful, evidence-based tools to support ongoing wellness and management of their condition. Mark's vision extends beyond providing cancer support for existing cancers to understanding their root causes and developing meaningful prevention measures. His work has helped hundreds of patients worldwide achieve meaningful client-reported improvements through the NORI Protocol.

Dr. Robert M. Hoffman brings over 55 years of distinguished cancer research experience to NORI as Scientific and Medical Advisor. As CEO of AntiCancer, Inc., Dr. Hoffman has been at the forefront of cancer research innovation for decades, contributing groundbreaking insights into cancer biology and treatment strategies. His extensive research portfolio and deep understanding of cancer mechanisms provide crucial scientific validation and guidance to the NORI Protocol. Dr. Hoffman's collaboration with NORI ensures that the nutritional oncology approach remains grounded in the latest scientific discoveries and evidence-based practices. His decades of experience in studying cancer at the cellular and molecular level inform the protocol's targeted approach to supporting metabolic health in cancer patients through nutritional intervention and natural compounds.

Dr. Daniel Thomas has practiced integrative oncology for 35 years, bringing invaluable clinical perspective to NORI's scientific team. As a Doctor of Osteopathic Medicine with a Master of Science degree, Dr. Thomas bridges the gap between conventional medical training and holistic, patient-centered care. His three and a half decades of experience consulting with cancer patients has given him unique insights into complementary wellness approaches beyond standard oncology protocols. Dr. Thomas's long-standing practice in integrative oncology—combining conventional treatments with evidence-based complementary approaches—makes him an ideal advisor for NORI's mission to expand support options for cancer patients. His clinical expertise ensures that the NORI Protocol is both scientifically sound and practically applicable for real-world patient care, helping to refine protocols based on actual patient outcomes and needs.